Peer Review History
Original SubmissionDecember 12, 2022 |
---|
PONE-D-22-34075LIN-35 is necessary in both the soma and germline for preserving fertility in Caenorhabditis elegans under moderate temperature stressPLOS ONE Dear Dr. Petrella, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 22 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Myon-Hee Lee, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. 4. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.
In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions. 5. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. 6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have investigated the soma and germline requirements of the C. elegans RB homolog LIN-35 in fertility under normal growth conditions and mild temperature stress. Using transgenes expressing lin-35 under a pan-somatic promoter or an intestinal promoter, there were able to show significant rescue effects of the brood size at 20° and 26°, as well as in upshift conditions. However, no rescue of the fertility is observed at 26°. Relative fertility is fully rescued in stressed (26°) condition compared to upshift conditions using the pan-somatic transgene. This tells that some lin-35(+) somatic activity is missing when lin-35 is exclusively expressed in the intestine. The authors added lin-35(+) expression in the somatic gonad to the one in the intestine, however, it did not increase the brood size. Altogether, lin-35 somatic expression partially rescues decreased brood size and fertility associated with temperature stress, but a germline intrinsic lin-35(+) activity might also be necessary for a fully functional germline. To test this, lin-35 is expressed under the control of the pie-1 or the mex-5 promoter. Both promoters show a rescue effect and relative fertility shows a complete rescue of the stress caused by upshift of the temperature. Then authors studied the effect of the maternal and the zygotic contributions of lin-35(+) on the brood size. Interestingly zygotic expression is sufficient to rescue the brood size to a wild type level at 26°. They further show that normal sperm is not able to compensate for all the defects, although they appear to localize properly in the spermatheca, except when lin-35(+) is expressed from an intestinal promoter at 26°. The authors also looked at oocyte formation and observed that lin-35 mutants expressing lin-35(+) under an intestinal promoter have a reduced number of oocytes at 26°. However, the pan-somatic promoter rescue almost completely the oocyte deficiency associated with lin-35 mutant. The authors conclude that LIN-35 is required both in the germline and in somatic tissue for the full reproduction capacity. Somatic LIN-35, but more predominantly germline LIN-35 are required for the germ cells to resist to mild temperature stress. The results are further interpreted in a discussion that is interesting, well written and supported by the literature on LIN-35 function that the authors appear to know thoroughly. Altogether, this study provides new insights in the function of LIN-35/RB in germline stress resistance and the maintenance of reproduction capacity. Comments -A large part of the results relies on rescue levels of brood size and fertility. However, levels of rescue using extra-chromosomal arrays are difficult to interpret. The MoSCI strategy from the Frøkjær-Jensen lab would have been more appropriate to avoid over-expression. Indeed, when the transgenes are expressed in wild type worms, they have a toxic effect on fertility which makes the results even more difficult to interpret. -The authors could comment on why they are not using the lin-35 promoter instead of the let-858 promoter? -Along the same line: why are the authors not testing the full rescue potential of a lin-35 transgene as a proof of concept? -DIC images provided, as well as the drawings of the worms (Figure 1) are of poor quality, and I hope that there will be of better resolution in the final version. -Figure 5 is labeled Figure 6 Reviewer #2: Previous studies have shown that C. elegans LIN-35, a pocket protein related to mammalian retinoblastoma protein (Rb), promotes fertility. LIN-35 is widely expressed throughout the body and functions in many tissues; at least some aspects of the lin-35 phenotype are temperature sensitive. The authors have a long-standing interest in germline stress sensitivity. Here, they investigate whether fertility is influenced by LIN-35 expression somatic tissues as well as the germline itself, and if this (these) function(s) is (are) particularly important under conditions of temperature stress. A complication in analyzing temperature effects in the germline is that even wildtype brood size drops at higher culture temperatures. The authors take pains to distinguish between this phenomenon and a lin-35-specific effect on brood size. The authors evaluated germline function by determining brood size and % fertile animals, referring to the latter phenotype by the generic term, “fertility.” The authors examine somatic involvement using transgenic strains where lin-35(+) are expressed under control of an intestinal or pan-somatic promoter in an otherwise lin-35(-) background. These transgenes rescue the lin-35(-) larval arrest phenotype, allowing strains to be maintained at high temperature. In contrast, they were evaluated germline function using germline-specific transgenes that could not rescue larval lethality, and hence they had to evaluate high temperature effects by upshifting larvae to high temperature once they were past the temperature-sensitive period. The authors describe expression patterns of the various transgenic lines as “data not shown,” but they should present those data (in a supplement). The authors present convincing evidence that both somatic transgenes can partially rescue the brood size defect – but not % fertile animals - at 20°C. Detailed comparisons show rescue was more complete with pan-somatic expression than with intestinal expression, indicating that lin-35 expression in multiple somatic tissues positively impacts brood size. Consistent with this, the fertility defect in animals grown at 26°C was better rescued when the pan-somatic transgene was present. They also assayed animals upshifted from 20° to 26°C as L4 larvae, and in this case somatic lin-35 expression did not rescue these animals. The authors’ interpretation of this result was not clear. Germline expressed transgenes partially rescued the brood size defect in animals raised at 20°C and animals upshifted to 26°C. Rescue was better than with somatic transgenes, indicating germline-intrinsic expression is critical. One confounding factor in these studies is that the somatically expressed transgenes are multicopy and present on extrachromosomal arrays, meaning they are very likely over-expressed compared to wildtype in those tissues where the promoter is active. These differences in expression level in transgenic lines may complicate some of the results, e.g., better suppression by intestinal expression in some cases and pan-somatic expression in others. The authors should include some discussion of this point. The authors investigated whether the germline phenotype reflected a maternal effect, as is the case for some other aspects of the lin-35 phenotype. They show that maternal expression contributes to brood size at 20°C, but zygotic expression is necessary in animals upshifted to 26°C. Moreover, brood sizes are restored to wt level by a lin-35(+) allele delivered from the male. The authors also identify sperm migration and oogenesis defects that likely contribute to the reduced brood size (sperm defect) and reduced % fertile animals (sperm and oocyte defects) at elevated temperatures. Intriguingly, the oogenesis defect can be rescued by pan-somatic lin-35 expression. Overall, the data presented are interesting, original, and support the authors’ conclusions. This manuscript will be of interest to germline researchers and those studying the impacts of stress on development. Specific comments The authors’ terminology is confusing at times. Specifically, they routinely use the term “fertility” to indicate % fertile animals in a population. However, sometimes they use it to indicate brood size. For example, on page 13, the authors present data indicating paternal rescue of the brood size, saying “At 26°C lin-35(n745) M-Z+ herms have an average brood that was sig different than wildtype herms (Fig. 3A). Thus, zygotic expression alone can strongly rescue fertility of lin-35 mutants at low temp and completely rescue fertility at high temps.” The very next statement is the section heading “Mating does not significantly rescue fertility in lin-35 mutants…” I suggest the authors use a more specific term when talking about the % fertile animals in a population, for example, “Mating does not significantly rescue percent fertile adults in lin-35 mutant populations under most conditions”. There are other examples… When introducing maternal vs embryonic expression, it would be helpful if the authors defined the “M” and “Z” terms for readers who might be new to the terminology. Typos and awkwardly worded sentences are sprinkled throughout the manuscript. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Chantal Wicky Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
LIN-35 is necessary in both the soma and germline for preserving fertility in Caenorhabditis elegans under moderate temperature stress PONE-D-22-34075R1 Dear Dr. Petrella, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Myon-Hee Lee, Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear Authors, Thanks for addressing my comments. The data is interpreted in an adequate way and the manuscript reads well now. Reviewer #2: The revised manuscript, PONE-D-22-34075R1, from Mikeworth et al. addresses all my comments on the initial submission. The authors now discuss the implications of -and caveats to - many findings that were previously unaddressed. The writing throughout is much clearer and more straight forward than on the original submission. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Chantal Wicky Reviewer #2: No ********** |
Formally Accepted |
PONE-D-22-34075R1 LIN-35 is necessary in both the soma and germline for preserving fertility in Caenorhabditis elegans under moderate temperature stress Dear Dr. Petrella: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Myon-Hee Lee Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .